We’re pleased to announce that we are now in a position to re-open trial recruitment in the UK and ROI in those centres that have the capacity to begin registering patients again. Please refer to the ...
News
Updated guidance on use of NSAIDs and COVID-19
There have been a number of reports, particularly on social media, suggesting that non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could worsen symptoms of COVID-19. In response to ...
Suspension of Registrations to the Add-Aspirin Trial
Registrations at all UK and ROI sites will be suspended from 17:00 on Thursday 9th April. Randomisation of patients registered for the run-in period by this date can proceed as per guidance found here ...
COVID-19 pandemic: Guidance for Add-Aspirin participants
In the current pandemic situation, we know that trial participants may have concerns or questions about taking their trial treatment and attending follow-up appointments. We have provided some general ...
UK Interdisciplinary Breast Cancer Symposium 2020 - Add-Aspirin Survivorship Poster
Click here to view the poster ...
News and Resources